Published in Hum Mol Genet on July 01, 1999
PANTHER: a library of protein families and subfamilies indexed by function. Genome Res (2003) 21.64
Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature (2004) 2.90
A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. Mol Cell (2007) 2.70
PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res (2014) 2.66
Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet (2008) 1.95
Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas"). Am J Hum Genet (2002) 1.66
Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations. Acta Neurochir Suppl (2008) 1.28
From germline towards somatic mutations in the pathophysiology of vascular anomalies. Hum Mol Genet (2009) 1.23
Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet (2009) 1.17
A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice. Am J Pathol (2005) 1.04
Pathogenesis of vascular anomalies. Clin Plast Surg (2011) 0.93
Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB. Hum Mol Genet (2013) 0.91
Vascular anomalies: from genetics toward models for therapeutic trials. Cold Spring Harb Perspect Med (2012) 0.91
Variable Somatic TIE2 Mutations in Half of Sporadic Venous Malformations. Mol Syndromol (2013) 0.91
Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. J Clin Invest (2015) 0.87
Somatic PIK3CA mutations as a driver of sporadic venous malformations. Sci Transl Med (2016) 0.86
[Skeletal vascular lesions in childhood and adolescence]. Pathologe (2004) 0.75
Genetic aspects of cerebrovascular malformations. Interv Neuroradiol (2001) 0.75
Facial cutaneo-mucosal venous malformations can develop independently of mutation of TEK gene but may be associated with excessive expression of Src and p-Src. J Negat Results Biomed (2017) 0.75
Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet (1980) 10.23
Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science (1990) 8.91
Hereditary hemorrhagic telangiectasia. N Engl J Med (1995) 6.91
Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients. Neurosurgery (1999) 6.89
Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet (1996) 5.15
Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell (1996) 5.10
Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet (1983) 4.02
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child (1981) 3.45
Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet (1999) 3.15
Somatic mutations in the neurofibromatosis 1 gene in gliomas and primitive neuroectodermal tumours. Anticancer Res (1996) 3.12
Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci U S A (1993) 3.01
Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci U S A (1992) 2.89
GAW10: simulated family data for a common oligogenic disease with quantitative risk factors. Genet Epidemiol (1997) 2.68
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. 1981. Int J Epidemiol (2011) 2.68
A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer (2008) 2.63
Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17. Exp Neurol (1989) 2.58
Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res (1997) 2.58
Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol (2000) 2.50
Axial mesodermal dysplasia spectrum. Am J Med Genet (1993) 2.43
Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol (1998) 2.36
A microsatellite genetic linkage map of human chromosome 18. Genomics (1993) 2.35
CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. Arch Dermatol (1994) 2.33
Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol (1998) 2.28
To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet (2003) 2.17
Utility of step sections: demonstration of additional pathological findings in biopsy samples initially diagnosed as actinic keratosis. Arch Dermatol (2000) 2.12
Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet (1993) 2.10
The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol (1998) 2.08
Diagnostic and genetical aspects of tuberous sclerosis. J Med Genet (1968) 2.03
Low dose rate teletherapy and tumour response. Australas Radiol (1993) 1.94
Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proc Natl Acad Sci U S A (1998) 1.93
Testing diphenylethylamine compounds for analgesic action. J Physiol (1945) 1.82
Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J (1993) 1.78
Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet (2000) 1.78
Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol (1992) 1.77
A community based investigation of the association between cannabis use, injuries and accidents. J Psychopharmacol (2005) 1.77
Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol (2001) 1.69
Congenital heart disease in Down's syndrome: two year prospective early screening study. BMJ (1991) 1.64
Refined assignment of the infantile neuronal ceroid lipofuscinosis (INCL, CLN1) locus at 1p32: incorporation of linkage disequilibrium in multipoint analysis. Genomics (1993) 1.61
SMAD4 mutations found in unselected HHT patients. J Med Genet (2006) 1.61
Anencephalus and spina bifida in Belfast (1964-1968). Ulster Med J (1973) 1.61
A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet (1995) 1.59
Familial Poland's syndrome. Ann Plast Surg (1989) 1.59
Hyperlipidaemic xanthomatosis. II. Mode of inheritance in 55 families with essential hyperlipidaemia and xanthomatosis. J Med Genet (1968) 1.59
A microsatellite genetic linkage map of human chromosome 13. Genomics (1993) 1.57
Genetic linkage studies in Alzheimer's disease families. Exp Neurol (1988) 1.57
Myelocystocele-cloacal exstrophy in a pedigree with a mitochondrial 12S rRNA mutation, aminoglycoside-induced deafness, pigmentary disturbances, and spinal anomalies. Teratology (2000) 1.54
Melanoma of the gallbladder: a review of cases seen at Duke University Medical Center. Cancer (1999) 1.54
The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet (1997) 1.53
Neuropathological changes in the white matter following head injury. J Neuropathol Exp Neurol (1967) 1.52
Linkage data for Marfan syndrome and markers on chromosomes 1 and 11. J Med Genet (1990) 1.52
Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res (2000) 1.52
Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res (1995) 1.50
Periconceptional vitamin supplementation and the prevention of neural tube defects in south-east England and Northern Ireland. J Med Genet (1984) 1.48
Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. Nat Genet (1996) 1.47
VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev Dyn (1998) 1.47
Comparative study of survival of autologous adipose tissue taken and transplanted by different techniques. Plast Reconstr Surg (1990) 1.45
Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor. Cell Growth Differ (1998) 1.44
Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1. J Biol Chem (1999) 1.44
Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer (2008) 1.43
A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol (1993) 1.43
Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. Ann Thorac Surg (1998) 1.42
Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am J Hum Genet (2001) 1.40
Advances in tissue expansion. Clin Plast Surg (1985) 1.39
A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genome Res (1995) 1.38
A comparison of neural tube defects identified by two independent routine recording systems for congenital malformations in Northern Ireland. Int J Epidemiol (1978) 1.38
Aggregation of platelets by Fusobacterium necrophorum. J Clin Microbiol (1985) 1.35
Chromosome analysis before birth and its value in genetic counselling. Br Med J (1971) 1.35
Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Am J Pathol (1994) 1.35
Raised alpha-fetoprotein levels in amniotic fluid and maternal serum in a triplet pregnancy in which one fetus had an omphalocoele. Br J Obstet Gynaecol (1975) 1.32
Cytogenetic analysis on children born of parents treated with immunosuppressive drugs. Proc Eur Dial Transplant Assoc (1978) 1.32
Recurrence risk of neural tube defects. Lancet (1980) 1.32
Genetic linkage of familial expansile osteolysis to chromosome 18q. Hum Mol Genet (1994) 1.32
A case of the orocraniodigital (Juberg-Hayward) syndrome. J Med Genet (1981) 1.31
Bestrophin gene mutations in patients with Best vitelliform macular dystrophy. Genomics (1999) 1.29
Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations. Acta Neurochir Suppl (2008) 1.28
Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat Genet (1994) 1.28
Factors associated with anencephalus and spina bifida in Belfast. Br J Prev Soc Med (1973) 1.27
Neural tube defect recurrence after 'partial' vitamin supplementation. J Med Genet (1989) 1.27
Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technol Assess (2003) 1.26
Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation (1995) 1.25
Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br J Cancer (1998) 1.25
The epidemiology of Huntington's disease in Northern Ireland. J Med Genet (1995) 1.25
Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res (1994) 1.24
Myelocele and alpha-fetoprotein in amniotic fluid. Lancet (1973) 1.24
Fusobacterium necrophorum and Bacteroides melaninogenicus as etiologic agents of foot rot in cattle. Am J Vet Res (1975) 1.24
Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet (1996) 1.23
Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest (1997) 1.23
Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4. Neurology (2007) 1.22
Central nervous system serotonin function and cardiovascular responses to stress. Psychosom Med (2001) 1.22
Occurrence of anaerobic bacteria in diseases of the dog and cat. Am J Vet Res (1979) 1.21
Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet (1995) 1.21
Missense mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy. Hum Mol Genet (1998) 1.21
Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD). Am J Hum Genet (1993) 1.20